21 CFR 520.1263a
§ 520.1263a Lincomycin tablets and syrup.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 520.1263a, § 520.1263a Lincomycin tablets and syrup, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87205
- Permanent ID
ys:prov:87205@1- SHA-256
9046851d1d9cb934836569cf145c3724893da05f3f42a6672287ebe55cf38b2f
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications.
(1) Each ounce of syrup contains lincomycin hydrochloride equivalent to either 25 or 50 milligrams (mg) lincomycin.
(2) Each tablet contains lincomycin hydrochloride equivalent to either 25 or 50 mg lincomycin.
(b) Sponsor. See No. 054771 in § 510.600(c) of this chapter.
(c) Conditions of use in dogs and cats—(1) Amount. Administer orally 10 mg per pound of body weight every 12 hours, or 7 mg per pound of body weight every 8 hours, for up to 12 days.
(2) Indications for use. For infections caused by gram-positive organisms which are sensitive to its action, particularly streptococci and staphylococci.
(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.